Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to rise 17.08% to -46 cents per share on August 11
Q2'25
Est.
$-0.47
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.05
The last earnings report on April 08 showed earnings per share of -40 cents, missing the estimate of -37 cents. With 44.47K shares outstanding, the current market capitalization sits at 52.50M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HOWL showed earnings on April 08, 2025. You can read more about the earnings report here.